http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2247133-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6261fdaf9d4f53cfeb44ecb846b4932f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-10 |
| filingDate | 1997-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dec72d59e29bc45fa5dbf63512510dc4 |
| publicationDate | 1997-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2247133-A1 |
| titleOfInvention | Tissue sealant compositions and methods of use thereof |
| abstract | Novel tissue sealant compositions are disclosed herein which can be formulated as a single-component. The compositions contain as essential elements thromboplastin and fibrinogen. Additional blood clotting factors such as Factors II, V, VII, X, and XIII can also be added. Also provided are methods for promoting tissue adhesion and/or hemostatus by administering the tissue adhesive compositions described herein. |
| priorityDate | 1996-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.